Početna › Rak štitnjače › Kalifornija
Kliničke studije za Rak štitnjače u državi Kalifornija
14 studija za Rak štitnjače traži sudionike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
Službeni tekst studije (engleski)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- i još 20
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069DESTINY-PANTUMOUR04
- Research Site, San Diego
U tijeku regrutacijaOpažajna studija
Od 18 do 130 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07124000Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
- University of California, San Francisco (UCSF), San Francisco
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT05786924Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
- The Unviersity of California, San Francisco (UCSF), San Francisco
U tijeku regrutacijaFaza 2
Od 2 do 25 godina · Oba spola · Ažurirano 24. srp 2026. · NCT06458036Navigation Intervention for Adolescent and Young Adult Cancer Survivors
- KP Southern California - Department of Research & Evaluation, Pasadena
U tijeku regrutacija
Od 21 do 45 godina · Oba spola · Ažurirano 6. srp 2026. · NCT07406087Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
- University of California, San Francisco, San Francisco
U tijeku regrutacijaFaza 2
Od 13 godina i više · Oba spola · Ažurirano 18. lip 2026. · NCT06961084A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- St Joseph Heritage Healthcare, Santa Rosa
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 27. svi 2026. · NCT03093116Active Surveillance of Papillary Thyroid Microcarcinoma
- Cedars-Sinai Medical Center, Los Angeles
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 7. svi 2026. · NCT02609685Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- City of Hope, Duarte
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
- Stanford Cancer Institute, Stanford
U tijeku regrutacijaFaza 1
Od 18 do 75 godina · Oba spola · Ažurirano 17. ožu 2026. · NCT04119024Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 10. ožu 2026. · NCT04742608Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
- City of Hope Medical Center, Duarte
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 23. velj 2026. · NCT05229341cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 godina i više · Oba spola · Ažurirano 20. sij 2026. · NCT05366881Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- University of California, San Francisco, San Francisco
U tijeku regrutacijaFaza 2
Od 2 do 99 godina · Oba spola · Ažurirano 14. stu 2025. · NCT05783323APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 27. lip 2025. · NCT03175224Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.